KYAN Therapeutics

KYAN Therapeutics is a clinical-stage artificial intelligence company that leverages its proprietary technology platform to transform the way patients are treated and therapies are developed. KYAN is revolutionizing the drug development and dose optimization process, with multiple pipeline combination therapies in development for oncology and infectious diseases. KYAN reduces risk and significantly accelerates the drug development process, identifying novel combination therapies with unprecedented efficacy and safety. KYAN’s clinically validated platform features unique disease mechanism and indication agnosticism.